Anti-CD38 therapy impairs SARS-CoV-2 vaccine response against alpha and delta variants in patients with multiple myeloma.

ABSTRACT:

SUBMITTER: Henriquez S 

PROVIDER: S-EPMC8674107 | biostudies-literature | 2022 Feb

REPOSITORIES: biostudies-literature